Transfection/Electroporation
NEPA21 Super Electroporator
ELEPO21 High Energy Electroporator
NEPA Porator
Cuvette Electroporation Applications
Adherent Electroporation Applications
In Vivo/In Utero/In Ovo/Ex Vivo
Electroporation Applications
CUY21 SC Electroporator
CUY21 EDIT Electroporator
Cuvettes/Chambers/Stand Holders
Cell-Culture-Plate Electrode
In Vivo/In Utero/In Ovo/Ex Vivo
Electrodes
Monitoring System
Accessories
Transfection/Sonoporation
Transfection/Microinjection
Electro Cell Fusion
Autofluorescence Quenching
Single-Cell/Micro-Particle Transfer
Programmable Freezer
Mechanical Vibration
Cuvette Electroporation Applications
Cell Culture Transfection
The NEPA21 electroporator makes it possible to achieve high transfection efficiency and high viability without resourse to special buffers for difficult-to-transfect cells: primary cells, stem cells, immune cells, blood cells and more. It works not only for plasmid DNA but also for siRNA, miRNA, shRNA, proteins and more.
Transfection into Primary Cells
See the cell images by clicking the cell names.
V: Viability, TE: Transfection Efficiency.
| Primary Cells | V | TE | Primary Cells | V | TE | |
| HUVEC Human Umbilical Vein Endothelial Cells | 95% | 75% | HUVEC Human Umbilical Vein Endothelial Cells | 100% | 92% | |
| HASM Human Airway Smooth Muscle Cells | 90% | 80% | Human Coronary-derived Smooth Muscle Cells | 82% | 67% | |
| Human Endometrial Stromal Cells | 95% | 90% | Human Uterine Cervical Fibroblasts | 65% | 90% | |
| Human Dermal Fibroblasts (HDF) | 95% | 89% | Human Dermal Fibroblasts (HDF) | 100% | 80% | |
| Human Keratinocytes | 70% | 65% | Human Malignant Mesothelioma Cells | 75% | 55% | |
| Human Meniscal Cells | 85% | 55% | Human Colorectal Cells | 53% | 80% | |
| Human T Cells | 58% | 90% | Human T Cells | 50% | 76% | |
| Human NK Cells | 48% | 86% | PBMC Peripheral Blood Mononuclear Cells |
93% | 66% | |
| Human Erythroblasts (CD34+ Progenitor Cells) | 79% | 43% | Human Chronic Lymphocytic Leukemia (CLL) | 82% | 70% | |
| Human Chronic Lymphocytic Leukemia (CLL) (mRNA) | 93% | 94% | Human Chronic Lymphocytic Leukemia (CLL) (mRNA) | 91% | 83% | |
| Human Osteoblast-like Cells derived from human skull | 64% | 74% | ||||
| Mouse Cerebral Cortex Neurons (E14) | 80% | 70% | Mouse Hippocampal Neurons (E14) |
80% | 60% | |
| Mouse Hippocampal Neurons (E17) | 65% | 70% | Mouse Neural Progenitor Cells | 80% | 60% | |
| Mouse Basal Ganglia Primordium | 91% | 71% | Mouse Cerebellar Granule Neurons | 91% | 65% | |
| Mouse DRG Neurons | 70% | 70% | MEF Mouse Embryonic Fibroblasts | 90% | 85% | |
| MEF Mouse Embryonic Fibroblasts | 75% | 85% | Mouse Embryonic Skin Fibroblasts | 80% | 50% | |
| Mouse External Genital Fibroblasts (E15.5) | 66% | 59% | Mouse Cervical Epithelial Cells | 82% | 55% | |
| Mouse Vascular Adventitial Fibroblasts | 90% | 50% | ||||
| BMMC Mouse Bone Marrow-Derived Mast Cells | 80% | 83% | Mouse peritoneal macrophages | 69% | 41% | |
| Mouse B cells (LPS stimulated) | 81% | 73% | Mouse B cells | 50% | 61% | |
| Mouse B cells (Unstimulated) | 84% | 83% | Mouse T cells (siRNA) | 88% | 77% | |
| Naive Mouse CD8+ T cells (Cas9 RNP) |
50% | 95% | Mouse Liver Cells | 70% | 50% | |
| Mouse Osteoblast Cells | 85% | 60% | Mouse Muscle Cells | 68% | 54% | |
| Rat Cerebral Cortex Neurons (E16) | 70% | 75% | Rat Hippocampal Neurons | 60% | 80% | |
| Rat Bulbar Neurons | 80% | 75% | Rat Cerebellar Neurons | 70% | 55% | |
| Rat Cerebellar Granule Cells | 70% | 80% | Rat Schwann Cells | 90% | 80% | |
| Rat Schwann Cells | 90% | 60% | OEC Rat Olfactory Ensheathing Cells |
93% | 46% | |
| Rat Müller Cells | 90% | 50% | REF Rat Embryonic Fibroblasts | 65% | 65% | |
| Rat Meningeal Fibroblasts | 90% | 95% | PASMC Rat Pulmonary Artery Smooth Muscle Cells | 72% | 70% | |
| Chick Embryonic Fibroblasts | 80% | 90% | Chick Embryonic Cerebellar Granule Cells | 86% | 83% | |
| Boine Cartilage Cells | 96% | 55% | Goat Embryonic Epithelial Fibroblasts |
80% | 55% | |
| Rabbit Spleen cells (B cells) | 70% | 45% | Canine Adipose-Derived Stromal Cells (ADSCs) | 65% |
We have a lot of data of primary-cell transfection with high efficiency and high viability. Please feel to free to contact us for the latest data.
Transfection into Stem Cells: ES, iPS, other stem cells, organoids and more
See the cell images by clicking the cell names.
V: Viability, TE: Transfection Efficiency.
| Stem Cells | V | TE | Stem Cells | V | TE | |
| Human iPS Cells (201B7) | 86% | 70% | Human iPS Cells | 80% | 69% | |
| Human iPS Cells | Human iPS Cells | |||||
| Human iPS Cells (201B7) | 85% | 94% | Human iPS Cells (201B7) | |||
| Human iPS Cells | 69% | 80% | Human iPS Cells | 73% | ||
| Human ES cells (H9 p.51) | 55% | 55% | Human ES Cells | |||
| Human Mesenchymal Stem cells (Primary) | 78% | 75% | Human Mesenchymal Stem Cells | 70% | 80% | |
| Human Neural Stem Cells | 97% | 95% | Human Neural Stem Cells | 80% | 83% | |
| Human Deciduous Teeth Stem Cells (SHED) | 90% | 92% | Human Nucleated Cells Including Hematopoietic Stem Cells (Before cell isolation) | 73% | 90% | |
| Mouse iPS Cells | 70% | 50% | ||||
| Mouse ES Cells | 80% | 75% | Mouse ES Cells | 80% | 68% | |
| Mouse ES Cells | 74% | 88% | Mouse ES cells (129 strain, R1/E) | 80% | 90% | |
| Mouse ES Cells | 70% | 100% | Mouse ES Cells | 80% | 90% | |
| Mouse iPS cell derived Neural Stem Cells | 86% | Mouse Neural Stem Cells | 90% | 80% | ||
| Mouse Neural Stem cells (Primary) | 80% | 60% | Mouse Neurospheres | 90% | 75% | |
| Mouse Neurospheres | Mouse Trophoblast Stem Cells | 59% | 47% | |||
| C3H/10T1/2 Mouse Mesenchymal Stem Cells |
70% | 85% | Mouse Mesenchymal Stem Cells | 99% | 89% | |
| Mouse Hematopoietic Stem Cells (c-Kit positive cells) | 66% | 45% | Rat ES Cells | 70% | 76% | Rat ES Cells | 60% | 80% |
| Human Normal Fundic Gastric Organoids | 68% | Mouse Fundic Gastric Organoids | 65% | |||
| Mouse Colorectal Cancer Organoids | 100% | 50% | Mouse Small Intestine Organoids |
We have a lot of data of stem-cell transfection with high efficiency and high viability. Please feel to free to contact us for the latest data.
Transfection into Cell Lines
See the cell images by clicking the cell names.
V: Viability, TE: Transfection Efficiency.
| Cell Line | V | TE | Cell Line | V | TE | |||
| Species: Human | ||||||||
| HeLa | Human Cervical Carcinoma Cells | 87% | 93% | HeLa-K | Human Cervical Carcinoma Cells | 90% | 90% | |
| 293 | Human Embryonic Kidney Cells | 92% | 91% | 293 | Human Embryonic Kidney Cells |
90% | 70% | |
| 293 | Human Embryonic Kidney Cells | 72% | 85% | 293T | Human Embryonic Kidney Cells |
90% | 95% | |
| 293T | Human Embryonic Kidney Cells | 83% | 87% | 293T | Human Embryonic Kidney Cells | 70% | 99% | |
| TIG-3 | Human Embryonic Lung Fibroblasts | 90% | 80% | TIG-7 | Human Embryonic Lung Fibroblasts | 89% | 76% | |
| MRC-5 | Human Embryonic Lung Fibroblasts | 85% | 90% | WI-38 | Human Embryonic Lung Fibroblasts |
80% | 70% | |
| HDF | Human Dermal Fibroblasts (106-05） | 90% | 90% | HaCat | Human Keratinocyte Cells |
96% | 69% | |
| HFE145 | Human Non-Cancerous Gastric Epithelial Cells | 80% | 50% | TIG-109 | Human Skin Fibroblasts | 70% | 60% | |
| BEAS-2B | Human Bronchial Epithelial Cells | 90% | 80% | BEAS-2B | Human Bronchial Epithelial Cells | 75% | 96% | |
| SUSM-1 | Human Fibroblasts | 77% | 71% | KMST-6 | Human Fibroblasts | 70% | 60% | |
| SEKI | Human Malignant Melanoma Cells | 80% | 75% | |||||
| HT1080 | Human Fibrosarcoma Cells | 93% | 81% | HT1080 | Human Fibrosarcoma Cells | 80% | 90% | |
| MG-63 | Human Osteosarcoma Cells | 70% | 80% | U2OS | Human Osteosarcoma Cells | 70% | 80% | |
| Saos-2 | Human Osteosarcoma Cells | 60% | 75% | Saos-2 | Human Osteosarcoma Cells | 80% | 70% | |
| PANC-1 | Human Pancreatic Carcinoma Cells | 78% | 70% | PANC-1 | Human Pancreatic Carcinoma Cells | 55% | 75% | |
| MIA-PaCa-2 | Human Pancreatic Carcinoma Cells | 80% | 77% | HepG2 | Human Hepatoma Cells | 88% | 76% | |
| HuH-7 | Human Hepatoma Cells | 90% | 86% | HuH-7 | Human Hepatoma Cells | 82% | 85% | |
| HLF | Human Liver Cancer Cells | 90% | 85% | TFK-1 | Human Bile Duct Adenocarcinoma Cells | 50% | 70% | |
| H69 | Human Small-Cell Lung Cancer Cells | 90% | 85% | NCI-H69 | Human Small-Cell Lung Cancer Cells |
97% | 70% | |
| LC319 | Human Lung Cancer Cells | 95% | 66% | H1299 | Human Lung Cancer Cells | 90% | 90% | |
| H1299 | Human Lung Cancer Cells | 80% | 80% | KB31 | Human Epidermoid Carcinoma Cells | 58% | 64% | |
| HSC-2 | Human Squamous Carcinoma Cells | 93% | 98% | HSC-3 | Human Squamous Carcinoma Cells | 93% | 98% | |
| Ca9-22 | Human Squamous Carcinoma Cells | 60% | 60% | HGF | Human Gingival Fibroblasts | |||
| HEp-2 | Human Laryngeal Carcinoma Cells | 70% | 90% | MCF-7 | Human Breast Cancer Cells | 81% | 65% | |
| MCF-7 | Human Breast Cancer Cells | 95% | 80% | MCF-7 | Human Breast Cancer Cells | 80% | 70% | |
| T47D | Human Breast Cancer Cells | 90% | 85% | BT-20 | Human Breast Cancer Cells | 70% | 80% | |
| MDA-MB-231 | Human Breast Cancer Cells | 85% | 90% | MCF 10A | Human Breast Cells | 90% | 80% | |
| MCF 10A | Human Breast Cells | MCF 10A | Human Breast Cells | 97% | 69% | |||
| A549 | Human Lung Adenocarcinoma Cells | 85% | 90% | NUGC-3 | Human Gastric Carcinoma Cells | 73% | 68% | |
| GC38 | Human Gastric Cancer Cells | 80% | 80% | MKN-45 | Human Gastric Cancer Cells | 78% | 73% | |
| Human Patient-Derived Gastric Cancer Cells | 44% | 74% | ||||||
| LNCaP | Human Prostate Carcinoma | 71% | 90% | DU145 | Human Prostate Cancer Cells |
94% | 60% | |
| PC-3 | Human Prostate Cancer Cells | 90% | 95% | PC-3 | Human prostate Cancer Cells |
86% | 55% | |
| PNT2 | Human Prostate Epithelial Cells | 85% | 80% | LoVo | Human Colon Adenocarcinoma Cells | 85% | 60% | |
| HCT116 | Human Colon Cancer Cells | 80% | 95% | HCT116 | Human Colon Cancer Cells | 80% | 80% | |
| HCT116 | Human Colon Cancer Cells | 95% | 90% | Caco-2 | Human Colon Cancer Cells | 95% | 80% | |
| Caco-2 | Human Colon Cancer Cells | 85% | 80% | SW620 | Human Colon Cancer Cells | 80% | 80% | |
| OVCAR-3 | Human Ovarian Carcinoma Cells | 90% | 79% | SKOV-3 | Human Ovarian Carcinoma Cells | 90% | 90% | |
| RMG-1 | Human Ovarian Clear Cell Adenocarcinoma | 97% | 67% | SK-N-SH | Human Neuroblastoma Cells | 95% | 95% | |
| SH-SY5Y | Human Neuroblastoma Cells | 60% | 90% | SH-SY5Y | Human Neuroblastoma Cells | 70% | 70% | |
| SH-SY5Y | Human Neuroblastoma Cells | 79% | 60% | NB9 | Human Neuroblastoma Cells | 70% | 70% | |
| NB69 | Human Neuroblastoma Cells | 95% | 80% | NB-39-nu | Human Neuroblastoma Cells | 60% | 63% | |
| KG-1-C | Human Oligodendroglial Cells | 85% | 60% | A172 | Human Glioblastoma Cells | 85% | 70% | |
| NP3 | Human Glioblastoma Cells | 98% | 62% | U87 MG | Human Glioblastoma/ Astrocytoma Cells |
70% | 55% | |
| 1321N1 | Human Astrocytoma Cells | 80% | 80% | U-251 | Human Glioblastoma Cells | 90% | 60% | |
| Immortalized Human Pericytes | 83% | 50% | iHAM-4 | Human Amniotic Mesenchymal Cells | 59% | 95% | ||
| Human Dental Pulp Cells | 85% | 69% | Human Dental Pulp Cells |
90% | 85% | |||
| HTR-8/Svneo | Human Trophoblast Cells | 95% | 67% | SRA 01/04 | Human Lens Epithelial Cells | 97% | 80% | |
| RPE | Retinal Pigment Epithelium Cells | 90% | 70% | RPE-1 | Retinal Pigment Epithelium Cells | 90% | 80% | |
| RPTEC | Human Renal Proximal Tubule Epithelial Cells | 70% | 85% | HK-2 | Human Renal Proximal Tubule Epithelial Cells | 50% | 90% | |
| Jurkat | Human T-cell Leukemia Cells | 73% | 94% | Jurkat | Human T-cell Leukemia Cells | 85% | 85% | |
| Jurkat | Human T-cell Leukemia Cells | 89% | 85% | Jurkat | Human T-cell Leukemia Cells | 99% | 92% | |
| ED40515 | Human T-cell Leukemia Cells | 82% | 84% | SNT16 | Human T-cell Lymphoma Cells | 85% | 84% | |
| Hut78 | Human T-cell Lymphoma Cells | 51% | 74% | |||||
| Jeko-1 | Human Mantle Cell Lymphoma (MCL) Cells | 82% | 71% | Jeko-1 | Human Mantle Cell Lymphoma (MCL) Cells | 80% | 63% | |
| MOLT-4 | Human Acute Lymphoblastic Leukemia Cells | 95% | 70% | MV4-11 | Human Acute Myeloid Leukemia Cells | 70% | 60% | |
| 697 | Human Pre-B Acute Lymphoblastic Leukemia Cells |
68% | 93% | MEC1 | Human Chronic Lymphocytic Leukemia Cells | >90% | >90% | |
| Nalm-6 | Human B-cell Precursor Leukemia Cells | 77% | 82% | Nalm-6 | Human B-cell Precursor Leukemia Cells | 97% | 76% | |
| KG-1 | Human Acute Myeloid Leukemia Cells | 60% | 65% | KG-1 | Human Acute Myeloid Leukemia Cells | 70% | 65% | |
| MOLM-16 | Human Acute Myeloid Leukemia Cells | 74% | 68% | PL-21 | Human Acute Myeloid Leukemia Cells | 51% | 73% | |
| Kasumi-1 | Human Acute Myeloid Leukemia Cells | 66% | 79% | USCD/AML1 | Human Leukemia Cells | 50% | 50% | |
| M7 | Human Acute Non Lymphocytic Leukemia | 85% | 80% | KOPT-K1 | Human T cell Acute Lymphoblastic Leukemia (T-ALL) Cells | 80% | 60% | |
| Loucy | Human T cell Acute Lymphoblastic Leukemia (T-ALL) Cells | 73% | 50% | GM12878 | Human B-Lymphoblastoid Cells | 93% | 83% | |
| T2 | Human T and B lymphoblast Cells | 97% | 97% | Human EBV-immortalized B Cells |
58% | 53% | ||
| Namalwa | Human Burkitt's Lymphoma Cells | 70% | 75% | Raji | Human Burkitt's Lymphoma Cells | 97% | 83% | |
| Raji | Human Burkitt's Lymphoma Cells | 95% | 96% | Raji | Human Burkitt's Lymphoma Cells | 85% | 79% | |
| Toledo | Human Burkitt's Lymphoma Cells | 81% | 60% | SU-DHL-4 | Human Burkitt's Lymphoma Cells | 79% | 68% | |
| eHAP1 | Human Haploid Cells | 72% | 65% | K562 | Human Chronic Myelogenous Leukemia Cells | 91% | 99% | |
| K562 | Human Chronic Myelogenous Leukemia Cells | >90% | >90% | K562 | Human Chronic Myelogenous Leukemia Cells | >90% | 94% | |
| HL-60 | Human Promyelocytic Leukemia Cells | 81% | 82% | HL-60 | Human Promyelocytic Leukemia Cells | 80% | 80% | |
| PLB-985 | Human Myeloid Leukemia Cells | 94% | 92% | Mutu Ⅰ | Human Burkitt Lymphoma Cells |
87% | 91% | |
| Mutu III | Human Burkitt Lymphoma Cells | 54% | 92% | Ramos | Human Burkitt Lymphoma Cells |
92% | 57% | |
| Ramos | Human Burkitt Lymphoma Cells | 83% | 57% | Ramos-Blue | Human Burkitt Lymphoma Cells |
80% | 55% | |
| Z-138 | Human Mantle Cell Lymphoma Cells | 93% | 86% | BJAB | Human EBV-negative Burkitt Lymphoma Cells | 96% | 96% | |
| SKM-1 | Human MDS-derived Leukaemia Cells | 88% | 83% | TK6 | Human B-Lymphoblast Cells | 84% | 79% | |
| THP-1 | Human Acute Monocytic Leukemia Cells | 76% | 63% | THP-1 | Human Acute Monocytic Leukemia Cells | 56% | 64% | |
| THP-1 | Human Acute Monocytic Leukemia Cells | 85% | 67% | THP-1 | Human Acute Monocytic Leukemia Cells | 67% | 85% | |
| HMC1.2 | Human Mast Leukemia Cells | 77% | 89% | NK-92MI | Human Natural Killer (NK) Cells |
83% | 95% | |
| KHYG-1 | Human Natural Killer (NK)Lleukemia Cells | 51% | 71% | MTA | Human Natural Killer- Like Leukemia Cells |
65% | 61% | |
| Species: Mouse | ||||||||
| NIH/3T3 | Mouse Embryonic Fibroblasts | 100% | 90% | NIH/3T3 | Mouse Embryonic Fibroblasts | 74% | 81% | |
| PT67 | Mouse Fibroblasts (RetroPack PT67 cell line) | 91% | 66% | 3T3-L1 | Mouse Embryonic Fibroblasts (preadipocytes) | 90% | 90% | |
| MEF | Mouse Embryonic Fibroblasts | 90% | 90% | MEF | Mouse Embryonic Fibroblasts | 80% | 90% | |
| STO | Mouse Embryonic Fibroblasts | 60% | 51% | N7 | Mouse Embryonic Hypothalamic cells (immortalized) | 75% | 100% | |
| P19C6 | Mouse Embryonic Carcinoma Cells | 90% | 50% | F9 | Mouse Testis Teratocarcinoma Cells | 85% | 95% | |
| HL-1 | Mouse Cardiac Muscle Cells | 70% | 70% | L | Mouse Fibroblasts | 90% | 65% | B16 | Mouse Melanoma Cells | 86% | 76% | B16 | Mouse Melanoma Cells | 77% | 83% |
| B16 | Mouse Melanoma Cells | 70% | 50% | MC3T3-E1 | Mouse Osteoblastic Cells | 85% | 75% | |
| C2C12 | Mouse Myoblast Cells | 94% | 90% | C2C12 | Mouse Myoblast Cells | 90% | 90% | |
| C2C12 | Mouse Myoblast Cells | 80% | 70% | C2C12 | Mouse Myoblast Cells | 94% | 96% | |
| bEnd.3 | Mouse Brain Endothelial Cells | 80% | 80% | NMuMG | Mouse Mammary Gland Epithelial Cells | 80% | 65% | |
| Mouse Podocytes (Kidney Epithelial cells) | 100% | 84% | Mouse Podocytes (Kidney Epithelial cells) | 66% | 68% | |||
| LLc1（LL/2） | Lewis Lung Cell Carcinoma 1 Cells | 87% | 81% | 4T1 | Mouse Breast Cancer Cells | 90% | 95% | |
| FM3A | Mouse Breast Cancer Cells | 77% | 57% | 3134 | Mouse Mammary Adenocarcinoma Cells | 100% | 70% | |
| Ehrlich | Mouse Ehrlich-Lettre Ascites Carcinoma Cells | 76% | 68% | Colon-26 | Mouse Colon Adenocarcinoma Cells | 95% | 90% | |
| Hepa1-6 | Mouse Hepatoma Cells | 50% | 98% | LM8 | Mouse Osteosarcoma Cells | 90% | 85% | |
| S180 | Mouse Sarcoma Cells | 72% | 57% | MS-1 | Mouse Pancreatic Endothelial Cells | 90% | 90% | |
| ddy Mouse Endometrial Cells | 60% | 80% | ID-8 | Mouse Ovarian Cancer Cells | 95% | 99% | ||
| AtT-20 | Mouse Pituitary Tumor Cells | 80% | 80% | TtT/GF | Mouse Pituitary Folliculo-Stellate-Like Cells | 65% | 83% | |
| Neuro-2a | Mouse Neuroblastoma Cells | 90% | 90% | GL261 E9 | Mouse Glioma Cells | 55% | 57% | |
| BV-2 | Mouse Microglial Cells | 80% | 80% | BV-2 | Mouse Microglial Cells | 92% | 70% | |
| BV-2 | Mouse Microglial Cells | 90% | 50% | mDP | Mouse Dental Pupilla Cells | 65% | 70% | |
| MEL | Mouse Erythroleukemia Cells | 70% | 50% | L1210 | Mouse Lymphocytic Leukemia Cells | 85% | 70% | |
| WR19L | Mouse T-Cell lymphoma Cells | 92% | 60% | EL4 | Mouse T-Cell Lymphoma Cells | 87% | 82% | |
| BA/F3 | Mouse pro-B Cells | 91% | 92% | BA/F3 | Mouse pro-B Cells | 90% | 90% | |
| A20 | Mouse B-cell Lymphoma Cells | 99% | 85% | A20 | Mouse B-cell Lymphoma Cells | 70% | 65% | |
| CH12F3 | Mouse B Lymphoma Cells | 74% | 77% | WEHI-231 | Mouse B-cell Lymphoma Cells | 98% | 73% | |
| P815 | Mouse Mastocytoma Cells | 67% | 68% | J774.1 | Mouse Macrophage-like Cells | 100% | 70% | |
| RAW264.7 | Mouse Macrophage-like Cells | 70% | 56% | RAW264.7 | Mouse Macrophage-like Cells | |||
| RAW264.7 | Mouse Macrophage-like Cells | 70% | 70% | RAW-D | Mouse Macrophage-like Cells | 80% | 80% | |
| MIN6 | Mouse Pancreatic Beta Cells | 57% | 71% | DC2.4 | Mouse Dendritic Cells | 42% | 66% | |
| XS106 | Mouse Dendritic Cells | 61% | 45% | mDC | Mouse Myeloid Dendritic Cells | 79% | 72% | |
| 416B | Mouse Primitive Myeloid Cells | 89% | 64% | 32D | Mouse Myeloid Cells | 88% | ||
| MLO-Y4 | Mouse Osteocyte-like cells | 99% | 59% | MC/9 | Mouse Mast Cells | 76% | 84% | |
| MC/9 | Mouse Mast Cells | 87% | 89% | BMBa | Mouse Bone Marrow-derived Basophils | 45% | 67% | |
| TS | Mouse Trophoblast Stem Cells | 59% | 47% | Mouse hybridoma cells (lymphocytes and myeloma cells) | 100% | 66% | ||
| Mouse T cell hybridoma cells Courtesy of Prof. Yokosuka and Dr. Wakamatsu, Department of Immunology, Tokyo Medical University |
69% | 90% | ||||||
| Species: Rat | ||||||||
| PC12 | Rat Adrenal Pheochromo-cytoma Cells | 90% | 70% | H9c2 | Rat Ventricular Myoblasts | 71% | 82% | |
| H9c2 | Rat Ventricular Myoblasts | 75% | 80% | REF | Rat Embryonic Fibroblasts | 90% | 99% | |
| RSC96 | Rat Schwann Cells | 70% | 85% | A7r5 | Rat Aortic Smooth Muscle Cells | 93% | 75% | |
| C6 | Rat Glioma Cells | 80% | 67% | |||||
| UMR106 | Rat Osteoblastic Cells | 80% | 70% | RCS | Rat Chondrosarcoma Cells | 75% | 50% | |
| SF2 | Rat Dental Epithelial Cells | 80% | 90% | HAT-7 | Rat Dental Epithelial Cells | 80% | 90% | |
| Species: Hamster | ||||||||
| CHO | Chinese Hamster Ovary Cells | 74% | 90% | CHO | Chinese Hamster Ovary Cells | 98% | 87% | |
| CHO | Chinese Hamster Ovary Cells | 97% | 97% | CHO-DG44 | Chinese Hamster Ovary Cells | 86% | 80% | |
| CHO-K1 | Chinese Hamster Ovary Cells | 95% | 95% | CHO-K1 | Chinese Hamster Ovary Cells | 90% | 99% | |
| CHO-S | Chinese Hamster Ovary Cells | 94% | 93% | |||||
| Other Species | ||||||||
| COS-7 | African Green Monkey Kidney fibroblasts | 61% | 89% | Vero | African Green Monkey Kidney Epithelial Cells | 85% | 85% | |
| MDCK | Madrin-Darby Canine Kidney Cells | 90% | 95% | MDCK | Madrin-Darby Canine Kidney Cells | 91% | 80% | |
| BFF | Bovine Fetal Fibroblasts | 93% | 71% | BFF | Bovine Fetal Fibroblasts | 78% | 72% | |
| CKT-1 | Bovine Kidney Epithelial Cells | 75% | 75% | Bovine Fibroblasts | 90% | 63% | ||
| BAEC | Bovine Aortic Endothelial Cells | 80% | 80% | LLC-PK1 | Pig Kidney Epithelial Cells | 80% | 85% | |
| CPK | Porcine Kidny Cells | 93% | 60% | PGCs | Chicken Primordial Germ Cells | 98% | 63% | |
| DT40 | Chichken B Cells | 72% | 85% | DT40 | Chichken B Cells | 71% | 60% | |
| A6 | Xenopus Kidney Epithelial Cells | 90% | 60% | Exosomes (labeled DNA oligos) | ||||
We have a lot of data of cell transfection with high efficiency and high viability. Please feel to free to contact us for the latest data.
